- call +1-201-465-4211
- email sales@marketsandresearch.biz
- Call +1-201-465-4211
- Email: sales@marketsandresearch.biz
The Pharmaceutical CDMO Services market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest study, due to COVID-19 pandemic, the global Pharmaceutical CDMO Services market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Innovative Medicine accounting for % of the Pharmaceutical CDMO Services global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Drug Substance Development and Manufacturing segment is altered to a % CAGR between 2022 and 2028.
Global key companies of Pharmaceutical CDMO Services include Recipharm AB, AMRI Global, Patheon N.V., Aenova Group, and Catalent, Inc., etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Pharmaceutical CDMO Services market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Drug Substance Development and Manufacturing
Specialized Services
Lab-based Services
Market segment by Application, can be divided into
Innovative Medicine
Patented Drug
Patent Expired Drug
Market segment by players, this report covers
Recipharm AB
AMRI Global
Patheon N.V.
Aenova Group
Catalent, Inc.
Amatsigroup
WuXi AppTec Group
Strides Pharma Science Limited
Piramal Pharma Solutions
Siegfried Ltd
Fareva Group
FAMAR Health Care Services
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Pharmaceutical CDMO Services product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Pharmaceutical CDMO Services, with revenue, gross margin and global market share of Pharmaceutical CDMO Services from 2019 to 2022.
Chapter 3, the Pharmaceutical CDMO Services competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Pharmaceutical CDMO Services market forecast, by regions, type and application, with revenue, from 2023 to 2028.
Chapter 11 and 12, to describe Pharmaceutical CDMO Services research findings and conclusion, appendix and data source.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Market Overview
1 Market Overview
1.1 Product Overview and Scope of Pharmaceutical CDMO Services
1.2 Classification of Pharmaceutical CDMO Services by Type
1.2.1 Overview: Global Pharmaceutical CDMO Services Market Size by Type: 2017 Versus 2021 Versus 2028
1.2.2 Global Pharmaceutical CDMO Services Revenue Market Share by Type in 2021
1.2.3 Drug Substance Development and Manufacturing
1.2.4 Specialized Services
1.2.5 Lab-based Services
1.3 Global Pharmaceutical CDMO Services Market by Application
1.3.1 Overview: Global Pharmaceutical CDMO Services Market Size by Application: 2017 Versus 2021 Versus 2028
1.3.2 Innovative Medicine
1.3.3 Patented Drug
1.3.4 Patent Expired Drug
1.4 Global Pharmaceutical CDMO Services Market Size & Forecast
1.5 Global Pharmaceutical CDMO Services Market Size and Forecast by Region
1.5.1 Global Pharmaceutical CDMO Services Market Size by Region: 2017 VS 2021 VS 2028
1.5.2 Global Pharmaceutical CDMO Services Market Size by Region, (2017-2022)
1.5.3 North America Pharmaceutical CDMO Services Market Size and Prospect (2017-2028)
1.5.4 Europe Pharmaceutical CDMO Services Market Size and Prospect (2017-2028)
1.5.5 Asia-Pacific Pharmaceutical CDMO Services Market Size and Prospect (2017-2028)
1.5.6 South America Pharmaceutical CDMO Services Market Size and Prospect (2017-2028)
1.5.7 Middle East and Africa Pharmaceutical CDMO Services Market Size and Prospect (2017-2028)
1.6 Market Drivers, Restraints and Trends
1.6.1 Pharmaceutical CDMO Services Market Drivers
1.6.2 Pharmaceutical CDMO Services Market Restraints
1.6.3 Pharmaceutical CDMO Services Trends Analysis
2 Company Profiles
2 Company Profiles
2.1 Recipharm AB
2.1.1 Recipharm AB Details
2.1.2 Recipharm AB Major Business
2.1.3 Recipharm AB Pharmaceutical CDMO Services Product and Solutions
2.1.4 Recipharm AB Pharmaceutical CDMO Services Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.1.5 Recipharm AB Recent Developments and Future Plans
2.2 AMRI Global
2.2.1 AMRI Global Details
2.2.2 AMRI Global Major Business
2.2.3 AMRI Global Pharmaceutical CDMO Services Product and Solutions
2.2.4 AMRI Global Pharmaceutical CDMO Services Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2.5 AMRI Global Recent Developments and Future Plans
2.3 Patheon N.V.
2.3.1 Patheon N.V. Details
2.3.2 Patheon N.V. Major Business
2.3.3 Patheon N.V. Pharmaceutical CDMO Services Product and Solutions
2.3.4 Patheon N.V. Pharmaceutical CDMO Services Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3.5 Patheon N.V. Recent Developments and Future Plans
2.4 Aenova Group
2.4.1 Aenova Group Details
2.4.2 Aenova Group Major Business
2.4.3 Aenova Group Pharmaceutical CDMO Services Product and Solutions
2.4.4 Aenova Group Pharmaceutical CDMO Services Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4.5 Aenova Group Recent Developments and Future Plans
2.5 Catalent, Inc.
2.5.1 Catalent, Inc. Details
2.5.2 Catalent, Inc. Major Business
2.5.3 Catalent, Inc. Pharmaceutical CDMO Services Product and Solutions
2.5.4 Catalent, Inc. Pharmaceutical CDMO Services Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5.5 Catalent, Inc. Recent Developments and Future Plans
2.6 Amatsigroup
2.6.1 Amatsigroup Details
2.6.2 Amatsigroup Major Business
2.6.3 Amatsigroup Pharmaceutical CDMO Services Product and Solutions
2.6.4 Amatsigroup Pharmaceutical CDMO Services Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6.5 Amatsigroup Recent Developments and Future Plans
2.7 WuXi AppTec Group
2.7.1 WuXi AppTec Group Details
2.7.2 WuXi AppTec Group Major Business
2.7.3 WuXi AppTec Group Pharmaceutical CDMO Services Product and Solutions
2.7.4 WuXi AppTec Group Pharmaceutical CDMO Services Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7.5 WuXi AppTec Group Recent Developments and Future Plans
2.8 Strides Pharma Science Limited
2.8.1 Strides Pharma Science Limited Details
2.8.2 Strides Pharma Science Limited Major Business
2.8.3 Strides Pharma Science Limited Pharmaceutical CDMO Services Product and Solutions
2.8.4 Strides Pharma Science Limited Pharmaceutical CDMO Services Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8.5 Strides Pharma Science Limited Recent Developments and Future Plans
2.9 Piramal Pharma Solutions
2.9.1 Piramal Pharma Solutions Details
2.9.2 Piramal Pharma Solutions Major Business
2.9.3 Piramal Pharma Solutions Pharmaceutical CDMO Services Product and Solutions
2.9.4 Piramal Pharma Solutions Pharmaceutical CDMO Services Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9.5 Piramal Pharma Solutions Recent Developments and Future Plans
2.10 Siegfried Ltd
2.10.1 Siegfried Ltd Details
2.10.2 Siegfried Ltd Major Business
2.10.3 Siegfried Ltd Pharmaceutical CDMO Services Product and Solutions
2.10.4 Siegfried Ltd Pharmaceutical CDMO Services Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10.5 Siegfried Ltd Recent Developments and Future Plans
2.11 Fareva Group
2.11.1 Fareva Group Details
2.11.2 Fareva Group Major Business
2.11.3 Fareva Group Pharmaceutical CDMO Services Product and Solutions
2.11.4 Fareva Group Pharmaceutical CDMO Services Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11.5 Fareva Group Recent Developments and Future Plans
2.12 FAMAR Health Care Services
2.12.1 FAMAR Health Care Services Details
2.12.2 FAMAR Health Care Services Major Business
2.12.3 FAMAR Health Care Services Pharmaceutical CDMO Services Product and Solutions
2.12.4 FAMAR Health Care Services Pharmaceutical CDMO Services Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12.5 FAMAR Health Care Services Recent Developments and Future Plans
3 Market Competition, by Players
3 Market Competition, by Players
3.1 Global Pharmaceutical CDMO Services Revenue and Share by Players (2019, 2020, 2021, and 2022)
3.2 Market Concentration Rate
3.2.1 Top 3 Pharmaceutical CDMO Services Players Market Share in 2021
3.2.2 Top 10 Pharmaceutical CDMO Services Players Market Share in 2021
3.2.3 Market Competition Trend
3.3 Pharmaceutical CDMO Services Players Head Office, Products and Services Provided
3.4 Pharmaceutical CDMO Services Mergers & Acquisitions
3.5 Pharmaceutical CDMO Services New Entrants and Expansion Plans
4 Market Size Segment by Type
4 Market Size Segment by Type
4.1 Global Pharmaceutical CDMO Services Revenue and Market Share by Type (2017-2022)
4.2 Global Pharmaceutical CDMO Services Market Forecast by Type (2023-2028)
5 Market Size Segment by Application
5 Market Size Segment by Application
5.1 Global Pharmaceutical CDMO Services Revenue Market Share by Application (2017-2022)
5.2 Global Pharmaceutical CDMO Services Market Forecast by Application (2023-2028)
6 North America by Country, by Type, and by Application
6 North America by Country, by Type, and by Application
6.1 North America Pharmaceutical CDMO Services Revenue by Type (2017-2028)
6.2 North America Pharmaceutical CDMO Services Revenue by Application (2017-2028)
6.3 North America Pharmaceutical CDMO Services Market Size by Country
6.3.1 North America Pharmaceutical CDMO Services Revenue by Country (2017-2028)
6.3.2 United States Pharmaceutical CDMO Services Market Size and Forecast (2017-2028)
6.3.3 Canada Pharmaceutical CDMO Services Market Size and Forecast (2017-2028)
6.3.4 Mexico Pharmaceutical CDMO Services Market Size and Forecast (2017-2028)
7 Europe by Country, by Type, and by Application
7 Europe by Country, by Type, and by Application
7.1 Europe Pharmaceutical CDMO Services Revenue by Type (2017-2028)
7.2 Europe Pharmaceutical CDMO Services Revenue by Application (2017-2028)
7.3 Europe Pharmaceutical CDMO Services Market Size by Country
7.3.1 Europe Pharmaceutical CDMO Services Revenue by Country (2017-2028)
7.3.2 Germany Pharmaceutical CDMO Services Market Size and Forecast (2017-2028)
7.3.3 France Pharmaceutical CDMO Services Market Size and Forecast (2017-2028)
7.3.4 United Kingdom Pharmaceutical CDMO Services Market Size and Forecast (2017-2028)
7.3.5 Russia Pharmaceutical CDMO Services Market Size and Forecast (2017-2028)
7.3.6 Italy Pharmaceutical CDMO Services Market Size and Forecast (2017-2028)
8 Asia-Pacific by Region, by Type, and by Application
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Pharmaceutical CDMO Services Revenue by Type (2017-2028)
8.2 Asia-Pacific Pharmaceutical CDMO Services Revenue by Application (2017-2028)
8.3 Asia-Pacific Pharmaceutical CDMO Services Market Size by Region
8.3.1 Asia-Pacific Pharmaceutical CDMO Services Revenue by Region (2017-2028)
8.3.2 China Pharmaceutical CDMO Services Market Size and Forecast (2017-2028)
8.3.3 Japan Pharmaceutical CDMO Services Market Size and Forecast (2017-2028)
8.3.4 South Korea Pharmaceutical CDMO Services Market Size and Forecast (2017-2028)
8.3.5 India Pharmaceutical CDMO Services Market Size and Forecast (2017-2028)
8.3.6 Southeast Asia Pharmaceutical CDMO Services Market Size and Forecast (2017-2028)
8.3.7 Australia Pharmaceutical CDMO Services Market Size and Forecast (2017-2028)
9 South America by Country, by Type, and by Application
9 South America by Country, by Type, and by Application
9.1 South America Pharmaceutical CDMO Services Revenue by Type (2017-2028)
9.2 South America Pharmaceutical CDMO Services Revenue by Application (2017-2028)
9.3 South America Pharmaceutical CDMO Services Market Size by Country
9.3.1 South America Pharmaceutical CDMO Services Revenue by Country (2017-2028)
9.3.2 Brazil Pharmaceutical CDMO Services Market Size and Forecast (2017-2028)
9.3.3 Argentina Pharmaceutical CDMO Services Market Size and Forecast (2017-2028)
10 Middle East & Africa by Country, by Type, and by Application
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Pharmaceutical CDMO Services Revenue by Type (2017-2028)
10.2 Middle East & Africa Pharmaceutical CDMO Services Revenue by Application (2017-2028)
10.3 Middle East & Africa Pharmaceutical CDMO Services Market Size by Country
10.3.1 Middle East & Africa Pharmaceutical CDMO Services Revenue by Country (2017-2028)
10.3.2 Turkey Pharmaceutical CDMO Services Market Size and Forecast (2017-2028)
10.3.3 Saudi Arabia Pharmaceutical CDMO Services Market Size and Forecast (2017-2028)
10.3.4 UAE Pharmaceutical CDMO Services Market Size and Forecast (2017-2028)
11 Research Findings and Conclusion
11 Research Findings and Conclusion
12 Appendix
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
List of Tables
Table 1. Global Pharmaceutical CDMO Services Revenue by Type, (USD Million), 2017 VS 2021 VS 2028
Table 2. Global Pharmaceutical CDMO Services Revenue by Application, (USD Million), 2017 VS 2021 VS 2028
Table 3. Global Market Pharmaceutical CDMO Services Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)
Table 4. Global Pharmaceutical CDMO Services Revenue (USD Million) by Region (2017-2022)
Table 5. Global Pharmaceutical CDMO Services Revenue Market Share by Region (2023-2028)
Table 6. Recipharm AB Corporate Information, Head Office, and Major Competitors
Table 7. Recipharm AB Major Business
Table 8. Recipharm AB Pharmaceutical CDMO Services Product and Solutions
Table 9. Recipharm AB Pharmaceutical CDMO Services Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 10. AMRI Global Corporate Information, Head Office, and Major Competitors
Table 11. AMRI Global Major Business
Table 12. AMRI Global Pharmaceutical CDMO Services Product and Solutions
Table 13. AMRI Global Pharmaceutical CDMO Services Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 14. Patheon N.V. Corporate Information, Head Office, and Major Competitors
Table 15. Patheon N.V. Major Business
Table 16. Patheon N.V. Pharmaceutical CDMO Services Product and Solutions
Table 17. Patheon N.V. Pharmaceutical CDMO Services Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 18. Aenova Group Corporate Information, Head Office, and Major Competitors
Table 19. Aenova Group Major Business
Table 20. Aenova Group Pharmaceutical CDMO Services Product and Solutions
Table 21. Aenova Group Pharmaceutical CDMO Services Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 22. Catalent, Inc. Corporate Information, Head Office, and Major Competitors
Table 23. Catalent, Inc. Major Business
Table 24. Catalent, Inc. Pharmaceutical CDMO Services Product and Solutions
Table 25. Catalent, Inc. Pharmaceutical CDMO Services Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 26. Amatsigroup Corporate Information, Head Office, and Major Competitors
Table 27. Amatsigroup Major Business
Table 28. Amatsigroup Pharmaceutical CDMO Services Product and Solutions
Table 29. Amatsigroup Pharmaceutical CDMO Services Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 30. WuXi AppTec Group Corporate Information, Head Office, and Major Competitors
Table 31. WuXi AppTec Group Major Business
Table 32. WuXi AppTec Group Pharmaceutical CDMO Services Product and Solutions
Table 33. WuXi AppTec Group Pharmaceutical CDMO Services Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 34. Strides Pharma Science Limited Corporate Information, Head Office, and Major Competitors
Table 35. Strides Pharma Science Limited Major Business
Table 36. Strides Pharma Science Limited Pharmaceutical CDMO Services Product and Solutions
Table 37. Strides Pharma Science Limited Pharmaceutical CDMO Services Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 38. Piramal Pharma Solutions Corporate Information, Head Office, and Major Competitors
Table 39. Piramal Pharma Solutions Major Business
Table 40. Piramal Pharma Solutions Pharmaceutical CDMO Services Product and Solutions
Table 41. Piramal Pharma Solutions Pharmaceutical CDMO Services Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 42. Siegfried Ltd Corporate Information, Head Office, and Major Competitors
Table 43. Siegfried Ltd Major Business
Table 44. Siegfried Ltd Pharmaceutical CDMO Services Product and Solutions
Table 45. Siegfried Ltd Pharmaceutical CDMO Services Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 46. Fareva Group Corporate Information, Head Office, and Major Competitors
Table 47. Fareva Group Major Business
Table 48. Fareva Group Pharmaceutical CDMO Services Product and Solutions
Table 49. Fareva Group Pharmaceutical CDMO Services Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 50. FAMAR Health Care Services Corporate Information, Head Office, and Major Competitors
Table 51. FAMAR Health Care Services Major Business
Table 52. FAMAR Health Care Services Pharmaceutical CDMO Services Product and Solutions
Table 53. FAMAR Health Care Services Pharmaceutical CDMO Services Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 54. Global Pharmaceutical CDMO Services Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)
Table 55. Global Pharmaceutical CDMO Services Revenue Share by Players (2019, 2020, 2021, and 2022)
Table 56. Breakdown of Pharmaceutical CDMO Services by Company Type (Tier 1, Tier 2 and Tier 3)
Table 57. Pharmaceutical CDMO Services Players Head Office, Products and Services Provided
Table 58. Pharmaceutical CDMO Services Mergers & Acquisitions in the Past Five Years
Table 59. Pharmaceutical CDMO Services New Entrants and Expansion Plans
Table 60. Global Pharmaceutical CDMO Services Revenue (USD Million) by Type (2017-2022)
Table 61. Global Pharmaceutical CDMO Services Revenue Share by Type (2017-2022)
Table 62. Global Pharmaceutical CDMO Services Revenue Forecast by Type (2023-2028)
Table 63. Global Pharmaceutical CDMO Services Revenue by Application (2017-2022)
Table 64. Global Pharmaceutical CDMO Services Revenue Forecast by Application (2023-2028)
Table 65. North America Pharmaceutical CDMO Services Revenue by Type (2017-2022) & (USD Million)
Table 66. North America Pharmaceutical CDMO Services Revenue by Type (2023-2028) & (USD Million)
Table 67. North America Pharmaceutical CDMO Services Revenue by Application (2017-2022) & (USD Million)
Table 68. North America Pharmaceutical CDMO Services Revenue by Application (2023-2028) & (USD Million)
Table 69. North America Pharmaceutical CDMO Services Revenue by Country (2017-2022) & (USD Million)
Table 70. North America Pharmaceutical CDMO Services Revenue by Country (2023-2028) & (USD Million)
Table 71. Europe Pharmaceutical CDMO Services Revenue by Type (2017-2022) & (USD Million)
Table 72. Europe Pharmaceutical CDMO Services Revenue by Type (2023-2028) & (USD Million)
Table 73. Europe Pharmaceutical CDMO Services Revenue by Application (2017-2022) & (USD Million)
Table 74. Europe Pharmaceutical CDMO Services Revenue by Application (2023-2028) & (USD Million)
Table 75. Europe Pharmaceutical CDMO Services Revenue by Country (2017-2022) & (USD Million)
Table 76. Europe Pharmaceutical CDMO Services Revenue by Country (2023-2028) & (USD Million)
Table 77. Asia-Pacific Pharmaceutical CDMO Services Revenue by Type (2017-2022) & (USD Million)
Table 78. Asia-Pacific Pharmaceutical CDMO Services Revenue by Type (2023-2028) & (USD Million)
Table 79. Asia-Pacific Pharmaceutical CDMO Services Revenue by Application (2017-2022) & (USD Million)
Table 80. Asia-Pacific Pharmaceutical CDMO Services Revenue by Application (2023-2028) & (USD Million)
Table 81. Asia-Pacific Pharmaceutical CDMO Services Revenue by Region (2017-2022) & (USD Million)
Table 82. Asia-Pacific Pharmaceutical CDMO Services Revenue by Region (2023-2028) & (USD Million)
Table 83. South America Pharmaceutical CDMO Services Revenue by Type (2017-2022) & (USD Million)
Table 84. South America Pharmaceutical CDMO Services Revenue by Type (2023-2028) & (USD Million)
Table 85. South America Pharmaceutical CDMO Services Revenue by Application (2017-2022) & (USD Million)
Table 86. South America Pharmaceutical CDMO Services Revenue by Application (2023-2028) & (USD Million)
Table 87. South America Pharmaceutical CDMO Services Revenue by Country (2017-2022) & (USD Million)
Table 88. South America Pharmaceutical CDMO Services Revenue by Country (2023-2028) & (USD Million)
Table 89. Middle East & Africa Pharmaceutical CDMO Services Revenue by Type (2017-2022) & (USD Million)
Table 90. Middle East & Africa Pharmaceutical CDMO Services Revenue by Type (2023-2028) & (USD Million)
Table 91. Middle East & Africa Pharmaceutical CDMO Services Revenue by Application (2017-2022) & (USD Million)
Table 92. Middle East & Africa Pharmaceutical CDMO Services Revenue by Application (2023-2028) & (USD Million)
Table 93. Middle East & Africa Pharmaceutical CDMO Services Revenue by Country (2017-2022) & (USD Million)
Table 94. Middle East & Africa Pharmaceutical CDMO Services Revenue by Country (2023-2028) & (USD Million)
List of Figures
Figure 1. Pharmaceutical CDMO Services Picture
Figure 2. Global Pharmaceutical CDMO Services Revenue Market Share by Type in 2021
Figure 3. Drug Substance Development and Manufacturing
Figure 4. Specialized Services
Figure 5. Lab-based Services
Figure 6. Pharmaceutical CDMO Services Revenue Market Share by Application in 2021
Figure 7. Innovative Medicine Picture
Figure 8. Patented Drug Picture
Figure 9. Patent Expired Drug Picture
Figure 10. Global Pharmaceutical CDMO Services Market Size, (USD Million): 2017 VS 2021 VS 2028
Figure 11. Global Pharmaceutical CDMO Services Revenue and Forecast (2017-2028) & (USD Million)
Figure 12. Global Pharmaceutical CDMO Services Revenue Market Share by Region (2017-2028)
Figure 13. Global Pharmaceutical CDMO Services Revenue Market Share by Region in 2021
Figure 14. North America Pharmaceutical CDMO Services Revenue (USD Million) and Growth Rate (2017-2028)
Figure 15. Europe Pharmaceutical CDMO Services Revenue (USD Million) and Growth Rate (2017-2028)
Figure 16. Asia-Pacific Pharmaceutical CDMO Services Revenue (USD Million) and Growth Rate (2017-2028)
Figure 17. South America Pharmaceutical CDMO Services Revenue (USD Million) and Growth Rate (2017-2028)
Figure 18. Middle East and Africa Pharmaceutical CDMO Services Revenue (USD Million) and Growth Rate (2017-2028)
Figure 19. Pharmaceutical CDMO Services Market Drivers
Figure 20. Pharmaceutical CDMO Services Market Restraints
Figure 21. Pharmaceutical CDMO Services Market Trends
Figure 22. Recipharm AB Recent Developments and Future Plans
Figure 23. AMRI Global Recent Developments and Future Plans
Figure 24. Patheon N.V. Recent Developments and Future Plans
Figure 25. Aenova Group Recent Developments and Future Plans
Figure 26. Catalent, Inc. Recent Developments and Future Plans
Figure 27. Amatsigroup Recent Developments and Future Plans
Figure 28. WuXi AppTec Group Recent Developments and Future Plans
Figure 29. Strides Pharma Science Limited Recent Developments and Future Plans
Figure 30. Piramal Pharma Solutions Recent Developments and Future Plans
Figure 31. Siegfried Ltd Recent Developments and Future Plans
Figure 32. Fareva Group Recent Developments and Future Plans
Figure 33. FAMAR Health Care Services Recent Developments and Future Plans
Figure 34. Global Pharmaceutical CDMO Services Revenue Share by Players in 2021
Figure 35. Pharmaceutical CDMO Services Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021
Figure 36. Global Top 3 Players Pharmaceutical CDMO Services Revenue Market Share in 2021
Figure 37. Global Top 10 Players Pharmaceutical CDMO Services Revenue Market Share in 2021
Figure 38. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)
Figure 39. Global Pharmaceutical CDMO Services Revenue Share by Type in 2021
Figure 40. Global Pharmaceutical CDMO Services Market Share Forecast by Type (2023-2028)
Figure 41. Global Pharmaceutical CDMO Services Revenue Share by Application in 2021
Figure 42. Global Pharmaceutical CDMO Services Market Share Forecast by Application (2023-2028)
Figure 43. North America Pharmaceutical CDMO Services Sales Market Share by Type (2017-2028)
Figure 44. North America Pharmaceutical CDMO Services Sales Market Share by Application (2017-2028)
Figure 45. North America Pharmaceutical CDMO Services Revenue Market Share by Country (2017-2028)
Figure 46. United States Pharmaceutical CDMO Services Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 47. Canada Pharmaceutical CDMO Services Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 48. Mexico Pharmaceutical CDMO Services Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. Europe Pharmaceutical CDMO Services Sales Market Share by Type (2017-2028)
Figure 50. Europe Pharmaceutical CDMO Services Sales Market Share by Application (2017-2028)
Figure 51. Europe Pharmaceutical CDMO Services Revenue Market Share by Country (2017-2028)
Figure 52. Germany Pharmaceutical CDMO Services Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. France Pharmaceutical CDMO Services Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 54. United Kingdom Pharmaceutical CDMO Services Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 55. Russia Pharmaceutical CDMO Services Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 56. Italy Pharmaceutical CDMO Services Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. Asia-Pacific Pharmaceutical CDMO Services Sales Market Share by Type (2017-2028)
Figure 58. Asia-Pacific Pharmaceutical CDMO Services Sales Market Share by Application (2017-2028)
Figure 59. Asia-Pacific Pharmaceutical CDMO Services Revenue Market Share by Region (2017-2028)
Figure 60. China Pharmaceutical CDMO Services Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Japan Pharmaceutical CDMO Services Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. South Korea Pharmaceutical CDMO Services Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. India Pharmaceutical CDMO Services Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. Southeast Asia Pharmaceutical CDMO Services Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 65. Australia Pharmaceutical CDMO Services Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 66. South America Pharmaceutical CDMO Services Sales Market Share by Type (2017-2028)
Figure 67. South America Pharmaceutical CDMO Services Sales Market Share by Application (2017-2028)
Figure 68. South America Pharmaceutical CDMO Services Revenue Market Share by Country (2017-2028)
Figure 69. Brazil Pharmaceutical CDMO Services Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 70. Argentina Pharmaceutical CDMO Services Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 71. Middle East and Africa Pharmaceutical CDMO Services Sales Market Share by Type (2017-2028)
Figure 72. Middle East and Africa Pharmaceutical CDMO Services Sales Market Share by Application (2017-2028)
Figure 73. Middle East and Africa Pharmaceutical CDMO Services Revenue Market Share by Country (2017-2028)
Figure 74. Turkey Pharmaceutical CDMO Services Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. Saudi Arabia Pharmaceutical CDMO Services Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. UAE Pharmaceutical CDMO Services Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 77. Methodology
Figure 78. Research Process and Data Source
Please feel free to write an email to us or to use our electronic ticketing system.
